Lyme disease vaccine given guarded approval in the USBMJ 1998; 316 doi: https://doi.org/10.1136/bmj.316.7146.1695 (Published 06 June 1998) Cite this as: BMJ 1998;316:1695
- Terri Rutter
An advisory committee to the US Food and Drug Administration has given a guarded recommendation that a new vaccine against Lyme disease should be licensed.
During clinical trials the vaccine was found to be significantly effective in preventing Lyme disease when given in three doses. Although the advisory committee agreed that the data presented by the manufacturer SmithKline Beecham met the requirements to show safety and efficacy—required by the agency in order to grant a license—it also expressed some reservations.
“In my view, …
Log in using your username and password
Log in through your institution
Sign up for a free trial